Date closed: 5/6/2015

Value: C$57.5 million

On May 6, 2015, ProMetic Life Sciences Inc. (ProMetic) completed the bought deal public offering of common shares in the capital of the Corporation (the Offering) through a syndicate of underwriters led by Canaccord Genuity Corp., and which included RBC Dominion Securities Inc., Beacon Securities Limited, TD Securities Inc. and Paradigm Capital Inc. (collectively, the Underwriters). ProMetic issued 22,137,500 common shares of the Corporation (including the full exercise of the over-allotment option) in connection with the Offering at a price of $2.60 per share for aggregate gross proceeds of C$57,557,500.

Prometic, headquartered in Laval, Quebec, is a biopharmaceutical company.   

BLG represented ProMetic with a team led by Pascal de Guise that included Yaniv Saragosti, Maxime Lemoyne, Lyne St. Pierre, Janinna Romanini, Kenza Bensaid and Johanne Thomas.